Evaluating Culture Media for Complex Cell Models

Beyond the cells themselves, culture media are arguably the primary determinant of success in mammalian cell culture and the wide range of applications it enables. Whether propagating primary tissue-derived cells, expanding stem cells, conducting experiments in 2D or 3D, or developing cell therapy products, the reliability and reproducibility of results depend on media that can provide just the right physiological conditions required for healthy growth and function. In this article, cell culture experts share practical guidance for evaluating both new media formulations and their suppliers.

The benefits of purchasing specialty media

Standard media formulations, such as MEM, DMEM, RPMI, along with their common modifications, while often sufficient for less demanding cell lines, can fall short when it comes to primary cells, 3D models, and other physiologically complex models. Developing customized media and culture protocols for these systems can require significant time and optimization. In such cases, commercially available specialty media may offer clear advantages, where improved performance, reduced development time, and streamlined workflows can justify costs.

“Specialty media with performance validation data packages could significantly reduce project timelines,” says Fang Tian, Ph.D., Director of Biological Content at ATCC. “Even with a published special media formulation on hand, assembling a lengthy list of supplements and ancillary reagents is time-consuming and prone to human error. Off-the-shelf specialty media kit products provide convenience, consistency and technical support.”

“The cost of specialty media is justified when they deliver functional outcomes that standard formulations cannot support,” says James Brooks, Ph.D., Director of Cell Biology at Thermo Fisher Scientific’s BioProduction Business. “For primary cells, this can mean formulations that extend culture lifespan while maintaining differentiation potential and physiological relevance. In 3D models, justification comes when media consistently enable organoids that display reproducible architecture and tissue-like gene expression—leading to more predictive results in drug discovery or disease modeling.”

Evaluating media performance

When evaluating new culture media, improved cell growth alone should not be the deciding factor. Researchers must consider a range of performance attributes that vary by culture type. For example, primary cells derived from tissue sources have limited lifespans and must retain their native phenotypes and functions, while stem cells require not only the maintenance of stemness and naïve states but also reliable differentiation into the appropriate cell lineage.

“Buyers need to pay close attention to the cell surface markers’ expression, cell morphology, and cell differentiation ability,” suggests Dr. Tian. “Primary cells directly isolated from fresh tissue and 3D culture should maintain their physiological relevance, which mimic in vivo conditions. The functional performance data to watch out for include lineage-specific markers, cell differentiation efficiency, cytokine secretion, barrier integrity, electrophysiological activity, 3D spheroid/organoid size, and uniformity.”

It is important to verify that the cells in culture continue to function under in vivo-like conditions. For T cells and NK cells, for example, some tests for function can include ”cytotoxicity against relevant targets at 24–72 hours, exhaustion, and memory phenotypes, and durability readouts like mitochondrial fitness tell whether expansions are producing potent cells that will persist in vivo,” says Yelena Bronevetsky, Ph.D., Senior Product Management Leader at Xcellbio.

Often, there is no single benchmark that can assess performance across all applications. The benchmarks that define an effective medium must be tailored to the biology of the cells themselves. “For patient-derived organoids, the most convincing data combine growth kinetics with fidelity to the tissue of origin, such as histology, lineage markers, and single-cell profiles. For pluripotent cells, the bar is stability; maintenance of pluripotency markers and karyotype across passages, and clean and efficient differentiation to the target lineage under physoxia,” adds Dr. Bronevetsky. “The best specialty media earn their premium by delivering functional cells or tissues that behave more like biology—under the conditions you will actually use.”

Other useful performance data can also include post-thaw recovery, viability over passages, and functional readouts such as enzyme activity or extracellular matrix production. “In the case of 3D cell models, key metrics extend to spheroid or organoid formation efficiency, reproducibility of size and architecture, and physiologically relevant outputs such as barrier function or drug metabolism. Evidence shows that hepatocyte spheroids cultured in 3D media exhibit more in vivo-like albumin secretion and cytochrome P450 activity than 2D monolayers, emphasizing the importance of media that support functional relevance,” says Dr. Brooks.

Mind the effects of oxygen levels

The gas composition of the culture may also be an important aspect to consider, as standard culture incubation conditions (typically 21% O₂, 5% CO₂, 1 atm) does not reflect true physiological conditions. Dr. Bronevetsky cautions that shifting to physiologic oxygen (“physoxia,” ~1–7% O₂), controlled hypoxia, or altering pressure can cause non-trivial changes in the culture media.

“Lowering O₂ and modestly increasing pressure raises dissolved CO₂, shifting bicarbonate buffering; some media will drift acidic unless you increase buffer capacity or adjust CO₂ setpoints. Redox-active components, like thiols and iron chelators, can behave differently at low O₂, altering ROS signaling. Antioxidant boosters, like N-acetylcysteine (NAC), that look helpful at 21% O₂ can mask desired hypoxia phenotypes,” cautions Dr. Bronevetsky. “Most media were built for a world of non-physiological oxygen; once you move toward the gas environment cells actually experience in tissue, you must verify that performance, chemistry, and stability still hold.”

When it comes to 3D cultures, the effects of O₂ diffusion are particularly pronounced. Careful oxygen management should be considered alongside media evaluation. “For 3D models, mitigate diffusion limits by controlling spheroid diameter and culture conditions so oxygen and nutrients reach the core; as spheroids enlarge, diffusion constraints produce hypoxic and eventually necrotic centers, so keeping spheroids below a few-hundred-micron range and optimizing oxygenation helps preserve viability,” advises Dr. Brooks.

Logistical considerations

Beyond the biological aspects of culture media, prospective buyers should also look into the practical side when selecting media. This can include available media formats, pack sizes, storage and packaging, protocols, shelf-life, and regulatory compliance.

Dr. Tian suggests asking questions such as: “Is the culture protocol easy to follow, can the media format and shelf-life work seamlessly with existing lab equipment and workflow, and are the media compliant with local and international regulations?”

“Donor-to donor variability, different tissue origins, and cell derivation processes can have significant impacts on the overall cell culture outcomes. Pilot testing and obtaining cell and media from the same vendor may increase the success of matching your interested cell type with specialty media,” adds Dr. Tian.

Having a solid understanding of reagent supply chains is particularly relevant in uncommon or specialized media components. The widely used supplement, fetal bovine serum (FBS), for instance, could face a tightening supply. Experts at Corning have offered tips to plan and prepare for a possible shortage. These include directly reaching out to suppliers and considering bulk orders.

“Lot-to-lot consistency is essential because variability in media composition can significantly affect reproducibility, particularly in sensitive primary, and 3D cultures,” says Dr. Brooks. “Industry guidance also emphasizes supplier practices, such as transparent change notifications, reliable supply chains, and technical support, as important determinants of long-term success. Finally, implementing strong quality control practices—including tracking lot numbers, monitoring supplier updates, and maintaining supply redundancy—for continuity in long-term culture systems.”